Minimizing Immune Response to AAV Gene Therapy

Time: 11:00 am
day: Post-Conference Discussion Day - Track A

Details:

  • Exploring novel immunosuppressive drugs and regimes to reduce immune response
  • Measuring immunogenicity risk and resulting impacts on trial designs & patient eligibility
  • Standardizing immune protocols? Considerations across different disease types and modalities

Speakers: